SCHEMBL9963589

SCHEMBL9963589

Cc1c2nc(NCC(=O)N3CCCC3)sc2cc2sc(NCC(=O)N3CCC(N4CC(C)OC(C)C4)CC3)nc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.43
ALDH1A1 P00352 5/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
TDP1 Q9NUW8 3/20 0.43
TP53 P04637 2/20 0.43
KMT2A Q03164 2/20 0.40
MAPT P10636 2/20 0.40
PTGS2 P35354 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C19 P33261 2/20 0.39
PDE7A Q13946 2/20 0.38
IRAK4 Q9NWZ3 1/20 0.37
MEN1 O00255 1/20 0.37
G6PD P11413 1/20 0.35
HPGD P15428 1/20 0.35
CACNA1B Q00975 1/20 0.35
APBA1 Q02410 1/20 0.35
HSD17B10 Q99714 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
LMNA P02545 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9963572 0.89 TP53 (0.51) KDM4EALDH1A1TDP1TP53MAPT
SCHEMBL9963549 0.84 ACHE (0.46) KDM4EALDH1A1TDP1TP53MAPT
SCHEMBL9963585 0.84 BCHE (0.45) KDM4EALDH1A1TDP1TP53KMT2A
SCHEMBL9963580 0.83 ACHE (0.45) KDM4EALDH1A1TP53KMT2APTGS2
SCHEMBL9963583 0.81 PTGS2 (0.42) ALDH1A1TP53MAPTPTGS2HPGD
SCHEMBL9963658 0.81 TP53 (0.42) KDM4EALDH1A1TDP1TP53MAPT
SCHEMBL9963479 0.80 PTGS2 (0.45) ALDH1A1SMN1; SMN2TP53KMT2AMAPT
SCHEMBL9963695 0.80 PTGS2 (0.49) KDM4EALDH1A1MAPTPTGS2HPGD
SCHEMBL9963574 0.80 PTGS2 (0.44) ALDH1A1SMN1; SMN2TP53KMT2AMAPT
SCHEMBL9963577 0.80 PTGS2 (0.44) ALDH1A1TP53MAPTPTGS2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2032583-B1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
WO-2007144370-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258857-A1 CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 KDM4E 3178/4885ALDH1A1 51/4885SMN1; SMN2 251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.